| 1 | WhatsApp-based sexual and reproductive health education for adolescents with perinatally acquired HIV: lessons learned from an mHealth pilot intervention in South Africa | 2.4 | 1 | Citations (PDF) |
| 2 | Epigenetic associations with kidney disease in individuals of African ancestry with <i>APOL1</i> high-risk genotypes and HIV | 0.8 | 1 | Citations (PDF) |
| 3 | Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications | 4.5 | 41 | Citations (PDF) |
| 4 | The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study | 8.2 | 42 | Citations (PDF) |
| 5 | A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2 | 8.9 | 6 | Citations (PDF) |
| 6 | Protein Expression of TLR2, TLR4, and TLR9 on Monocytes in TB, HIV, and TB/HIV | 2.8 | 3 | Citations (PDF) |
| 7 | Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results | 4.0 | 9 | Citations (PDF) |
| 8 | Trends in body mass index for people with and without HIV: Pooled analysis of nationally-representative health surveys from 10 countries and 173,800 adults in Africa | 2.2 | 0 | Citations (PDF) |
| 9 | The Association Between Rheumatic Disease Therapies and Cardiovascular Outcomes in People with HIV—A Retrospective Cohort Study | 2.6 | 0 | Citations (PDF) |
| 10 | Epigenetic Age Acceleration Markers Are Associated With Physiologic Frailty and All-Cause Mortality in People With Human Immunodeficiency Virus | 5.6 | 17 | Citations (PDF) |
| 11 | Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study | 5.6 | 11 | Citations (PDF) |
| 12 | A cluster randomized controlled trial of a modified vaccination
clinical reminder for primary care providers. | 3.0 | 6 | Citations (PDF) |
| 13 | Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial | 8.3 | 22 | Citations (PDF) |
| 14 | Differential expression of chemokine receptors on monocytes in TB and HIV S | 3.6 | 5 | Citations (PDF) |
| 15 | U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment | 3.6 | 23 | Citations (PDF) |
| 16 | Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus | 5.6 | 53 | Citations (PDF) |
| 17 | Patient Experiences with Telemedicine for HIV Care During the First COVID-19 Wave in Atlanta, Georgia | 1.5 | 21 | Citations (PDF) |
| 18 | Immune health grades: Finding resilience in the COVID-19 pandemic and beyond | 2.6 | 5 | Citations (PDF) |
| 19 | Who’s slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first‐line HIV treatment in Uganda and South Africa | 2.9 | 7 | Citations (PDF) |
| 20 | Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support | 7.7 | 80 | Citations (PDF) |
| 21 | Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population | 5.6 | 16 | Citations (PDF) |
| 22 | Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America | 2.7 | 4 | Citations (PDF) |
| 23 | Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy | 2.4 | 8 | Citations (PDF) |
| 24 | Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression | 4.3 | 18 | Citations (PDF) |
| 25 | Mobile Phone–Based Intervention Among Adolescents Living With Perinatally Acquired HIV Transitioning from Pediatric to Adult Care: Protocol for the Interactive Transition Support for Adolescents Living With HIV using Social Media (InTSHA) Study | 1.2 | 16 | Citations (PDF) |
| 26 | Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial | 10.3 | 179 | Citations (PDF) |
| 27 | Cognitively Based Compassion Training for HIV Immune Nonresponders—An Attention-Placebo Randomized Controlled Trial | 1.9 | 6 | Citations (PDF) |
| 28 | Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial | 10.3 | 64 | Citations (PDF) |
| 29 | The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States | 2.3 | 7 | Citations (PDF) |
| 30 | CD4/CD8 Ratio and Cancer Risk Among Adults With HIV | 5.2 | 60 | Citations (PDF) |
| 31 | Association of secretor status and recent norovirus infection with gut microbiome diversity metrics in a Veterans Affairs population | 0.8 | 0 | Citations (PDF) |
| 32 | Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection | 9.1 | 21 | Citations (PDF) |
| 33 | Detection of HIV virologic failure and switch to second-line therapy: a systematic review and meta-analysis of data from sub-Saharan Africa | 0.8 | 7 | Citations (PDF) |
| 34 | Biological ageing with HIV infection: evaluating the geroscience hypothesis | 6.3 | 57 | Citations (PDF) |
| 35 | Unravelling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2 | 0.8 | 2 | Citations (PDF) |
| 36 | Rapid Antiretroviral Therapy Program: Development and Evaluation at a Veterans Affairs Medical Center in the Southern United States | 2.8 | 17 | Citations (PDF) |
| 37 | Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial | 10.3 | 98 | Citations (PDF) |
| 38 | Diet Quality, Muscle Mass, Strength and Function in Older Veterans With HIV | 0.2 | 2 | Citations (PDF) |
| 39 | The Impact of Churn on HIV Outcomes in a Southern United States Clinical Cohort | 0.8 | 6 | Citations (PDF) |
| 40 | Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial | 8.9 | 6 | Citations (PDF) |
| 41 | The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health Threats | 0.8 | 2 | Citations (PDF) |
| 42 | Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015 | 4.0 | 29 | Citations (PDF) |
| 43 | Clinical Effectiveness of Integrase Strand Transfer Inhibitor–Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada | 5.6 | 11 | Citations (PDF) |
| 44 | DNA methylation biomarker selected by an ensemble machine learning approach predicts mortality risk in an HIV-positive veteran population | 3.3 | 18 | Citations (PDF) |
| 45 | Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada | 5.6 | 87 | Citations (PDF) |
| 46 | Incidence, Etiology, and Severity of Acute Gastroenteritis Among Prospectively Enrolled Patients in 4 Veterans Affairs Hospitals and Outpatient Centers, 2016–2018 | 5.6 | 31 | Citations (PDF) |
| 47 | Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019 | 5.6 | 127 | Citations (PDF) |
| 48 | Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 | 25.1 | 1,643 | Citations (PDF) |
| 49 | COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study | 3.2 | 28 | Citations (PDF) |
| 50 | Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study | 2.5 | 5 | Citations (PDF) |
| 51 | Impact of pre-existing drug resistance on risk of virological failure in South Africa | 3.2 | 16 | Citations (PDF) |
| 52 | 2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings | 3.2 | 4 | Citations (PDF) |
| 53 | Designing COVID-19 mortality predictions to advance clinical outcomes: Evidence from the Department of Veterans Affairs | 3.3 | 5 | Citations (PDF) |
| 54 | Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting | 2.8 | 1 | Citations (PDF) |
| 55 | Depression as a Risk Factor for Incident Ischemic Stroke Among HIV‐Positive Veterans in the Veterans Aging Cohort Study | 4.3 | 13 | Citations (PDF) |
| 56 | Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study | 2.1 | 3 | Citations (PDF) |
| 57 | The potential use of digital health technologies in the African context: a systematic review of evidence from Ethiopia | 13.9 | 130 | Citations (PDF) |
| 58 | Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART | 4.5 | 25 | Citations (PDF) |
| 59 | Mortality Among Persons Entering HIV Care Compared With the General U.S. Population | 8.9 | 47 | Citations (PDF) |
| 60 | Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV | 2.0 | 6 | Citations (PDF) |
| 61 | Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial | 10.3 | 646 | Citations (PDF) |
| 62 | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021 | 14.8 | 107 | Citations (PDF) |
| 63 | PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV | 2.5 | 13 | Citations (PDF) |
| 64 | Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial | 10.3 | 151 | Citations (PDF) |
| 65 | C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIALChest, 2021, 160, A2522-A2524 | 0.5 | 1 | Citations (PDF) |
| 66 | Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa | 8.9 | 19 | Citations (PDF) |
| 67 | Adapting the Surveillance Platform for Enteric and Respiratory Infectious Organisms at United States Veterans Affairs Medical Centers (SUPERNOVA) for COVID-19 Among Hospitalized Adults: Surveillance Protocol | 2.9 | 3 | Citations (PDF) |
| 68 | HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs | 3.6 | 26 | Citations (PDF) |
| 69 | Weight gain stopping/switch rules for antiretroviral clinical trialsAids, 2021, 35, S183-S188 | 2.4 | 21 | Citations (PDF) |
| 70 | Barriers and Facilitators to Advance Care Panning Among Veterans Aging With HIV | 0.1 | 0 | Citations (PDF) |
| 71 | Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 | 14.8 | 84 | Citations (PDF) |
| 72 | Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first‐line therapy in South Africa: a case–control cohort study | 3.6 | 11 | Citations (PDF) |
| 73 | Epigenetic Associations With Estimated Glomerular Filtration Rate Among Men With Human Immunodeficiency Virus Infection | 5.6 | 27 | Citations (PDF) |
| 74 | Associations between chronic pain, analgesic use and physical therapy among adults living with HIV in Atlanta, Georgia: a retrospective cohort study | 1.5 | 11 | Citations (PDF) |
| 75 | CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy | 2.5 | 16 | Citations (PDF) |
| 76 | Noncommunicable Diseases: Yet Another Challenge for Human Immunodeficiency Virus Treatment and Care in Sub-Saharan Africa | 5.6 | 7 | Citations (PDF) |
| 77 | Validating Self‐Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV | 3.0 | 17 | Citations (PDF) |
| 78 | Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 | 4.0 | 48 | Citations (PDF) |
| 79 | Community‐Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV | 4.3 | 9 | Citations (PDF) |
| 80 | High Baseline Viremia: An Achilles Heel for Integrase Inhibitor–Based Antiretroviral Therapy? | 5.6 | 0 | Citations (PDF) |
| 81 | A complex system of chemokines may hold the key to optimal CD4+ T-cell recovery after antiretroviral therapy | 9.0 | 0 | Citations (PDF) |
| 82 | A packaged intervention to improve viral load monitoring within a deeply rural health district of South Africa | 2.7 | 10 | Citations (PDF) |
| 83 | Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections | 2.9 | 27 | Citations (PDF) |
| 84 | Positive Health Check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care | 1.9 | 11 | Citations (PDF) |
| 85 | Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al | 5.6 | 0 | Citations (PDF) |
| 86 | Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial | 2.6 | 15 | Citations (PDF) |
| 87 | Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GeorgiaAids, 2020, 34, 1789-1794 | 2.4 | 42 | Citations (PDF) |
| 88 | CrAssphage as a Novel Tool to Detect Human Fecal Contamination on Environmental Surfaces and Hands | 4.0 | 53 | Citations (PDF) |
| 89 | Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al | 5.6 | 2 | Citations (PDF) |
| 90 | Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial | 1.8 | 32 | Citations (PDF) |
| 91 | The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak | 36.5 | 36 | Citations (PDF) |
| 92 | Physical Therapy for Chronic Pain Mitigation and Opioid Use Reduction Among People Living with Human Immunodeficiency Virus in Atlanta, GA: A Descriptive Case Series | 1.5 | 12 | Citations (PDF) |
| 93 | Increased Retention in Care After a Palliative Care Referral Among People Living With HIV | 1.9 | 7 | Citations (PDF) |
| 94 | The Intersection of HIV, Diabetes, and Race: Exploring Disparities in Diabetes Care among People Living with HIV | 1.7 | 14 | Citations (PDF) |
| 95 | FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C | 6.0 | 34 | Citations (PDF) |
| 96 | Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection | 4.3 | 47 | Citations (PDF) |
| 97 | An Innovative Physical Therapy Intervention for Chronic Pain Management and Opioid Reduction Among People Living with HIV | 2.4 | 3 | Citations (PDF) |
| 98 | Implementation of “Treat‐all” at adult <scp>HIV</scp> care and treatment sites in the Global Ie<scp>DEA</scp> Consortium: results from the Site Assessment Survey | 3.6 | 39 | Citations (PDF) |
| 99 | Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial | 4.8 | 56 | Citations (PDF) |
| 100 | Microvascular Disease, Peripheral Artery Disease, and Amputation | 10.1 | 166 | Citations (PDF) |
| 101 | Impact of Availability of Telehealth Programs on Documented HIV Viral Suppression: A Cluster-Randomized Program Evaluation in the Veterans Health Administration | 0.8 | 32 | Citations (PDF) |
| 102 | Management of Virologic Failure and HIV Drug Resistance | 3.6 | 61 | Citations (PDF) |
| 103 | HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database | 4.3 | 172 | Citations (PDF) |
| 104 | Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial | 3.1 | 19 | Citations (PDF) |
| 105 | Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV | 5.0 | 14 | Citations (PDF) |
| 106 | Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals | 2.3 | 27 | Citations (PDF) |
| 107 | The Impacts of Residential Location on the Risk of HIV Virologic Failure Among ART Users in Durban, South Africa | 2.0 | 5 | Citations (PDF) |
| 108 | No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial | 0.8 | 17 | Citations (PDF) |
| 109 | Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era | 1.5 | 11 | Citations (PDF) |
| 110 | Viral suppression among persons in HIV care in the United States during 2009–2013: sampling bias in Medical Monitoring Project surveillance estimates | 1.7 | 7 | Citations (PDF) |
| 111 | Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia | 2.7 | 30 | Citations (PDF) |
| 112 | Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study | 1.9 | 25 | Citations (PDF) |
| 113 | DNA Methylation Markers of Type 2 Diabetes Mellitus Among Male Veterans With or Without Human Immunodeficiency Virus Infection | 4.0 | 27 | Citations (PDF) |
| 114 | Author response: Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members 2019, , | | 1 | Citations (PDF) |
| 115 | Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial | 5.6 | 84 | Citations (PDF) |
| 116 | Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV‐Positive and HIV‐Negative Individuals in VACS (Veterans Aging Cohort Study) | 4.3 | 56 | Citations (PDF) |
| 117 | 2262. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era | 0.8 | 0 | Citations (PDF) |
| 118 | 1648. Incidence of Norovirus and Rotavirus From Multisite Active Surveillance in Veteran’s Affairs Hospitals, December 2016–February 2018: Results From the SUPERNOVA Network | 0.8 | 3 | Citations (PDF) |
| 119 | 652. What Is Blood Got to Do with It? Genetic Susceptibility to Norovirus and Rotavirus Infection: Results From the SUPERNOVA Network | 0.8 | 0 | Citations (PDF) |
| 120 | Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy | 1.9 | 13 | Citations (PDF) |
| 121 | Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality | 4.3 | 56 | Citations (PDF) |
| 122 | Predicting diabetes risk among HIV-positive and HIV-negative womenAids, 2018, 32, 2767-2775 | 2.4 | 11 | Citations (PDF) |
| 123 | Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection | 1.7 | 5 | Citations (PDF) |
| 124 | Room for Improvement: The HIV–Diabetes Care Continuum Over 15 Years in the Women’s Interagency HIV Study | 0.8 | 11 | Citations (PDF) |
| 125 | Pathways to Retention in HIV Care Among U.S. Veterans | 1.5 | 2 | Citations (PDF) |
| 126 | 2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings | 3.2 | 5 | Citations (PDF) |
| 127 | Progress in achieving long-term HIV remission | 3.6 | 8 | Citations (PDF) |
| 128 | Geospatial mapping to identify feasible HIV prevention and treatment strategies that target specific settings | 1.8 | 2 | Citations (PDF) |
| 129 | The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients | 1.9 | 26 | Citations (PDF) |
| 130 | Retention in HIV care depends on patients’ perceptions of the clinic experience | 1.5 | 12 | Citations (PDF) |
| 131 | Oral microbiome in HIV-associated periodontitis | 1.3 | 51 | Citations (PDF) |
| 132 | Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure | 1.9 | 17 | Citations (PDF) |
| 133 | FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients | 10.0 | 36 | Citations (PDF) |
| 134 | Hypertension in HIV-Infected Adults Compared with Similar but Uninfected Adults in China: Body Mass Index-Dependent Effects of Nadir CD4 Count | 1.5 | 16 | Citations (PDF) |
| 135 | HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer | 1.9 | 18 | Citations (PDF) |
| 136 | Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms | 4.0 | 39 | Citations (PDF) |
| 137 | Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration | 9.0 | 36 | Citations (PDF) |
| 138 | Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study | 8.9 | 62 | Citations (PDF) |
| 139 | Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study | 2.0 | 16 | Citations (PDF) |
| 140 | CTLA-4+PD-1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques | 16.7 | 158 | Citations (PDF) |
| 141 | The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates | 2.0 | 16 | Citations (PDF) |
| 142 | A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDSAids, 2017, 31, 1765-1769 | 2.4 | 20 | Citations (PDF) |
| 143 | Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive U.S. veterans | 2.4 | 55 | Citations (PDF) |
| 144 | Code Saturation Versus Meaning Saturation | 2.2 | 3,244 | Citations (PDF) |
| 145 | Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals | 3.4 | 7 | Citations (PDF) |
| 146 | Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors | 4.5 | 93 | Citations (PDF) |
| 147 | Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with menAids, 2016, 30, 1305-1308 | 2.4 | 9 | Citations (PDF) |
| 148 | Novel Predictors of Poor Retention Following a Down-Referral from a Hospital-Based Antiretroviral Therapy Program in South Africa | 1.5 | 2 | Citations (PDF) |
| 149 | Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality | 5.6 | 42 | Citations (PDF) |
| 150 | Treatment options after virological failure of first-line tenofovir-based regimens in South AfricaAids, 2016, 30, 1137-1140 | 2.4 | 18 | Citations (PDF) |
| 151 | An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype | 3.2 | 8 | Citations (PDF) |
| 152 | Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study | 8.9 | 247 | Citations (PDF) |
| 153 | Increased Prevalence of Colorectal Carcinoma (CRC) in a HIV + Cohort: A Single-Center Retrospective Study | 0.4 | 0 | Citations (PDF) |
| 154 | Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States | 8.9 | 112 | Citations (PDF) |
| 155 | Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patientsAids, 2015, 29, 1113-1115 | 2.4 | 11 | Citations (PDF) |
| 156 | Concurrent use of traditional medicine and ART: Perspectives of patients, providers and traditional healers in Durban, South Africa | 2.2 | 31 | Citations (PDF) |
| 157 | Integrating Early Palliative Care for Patients With HIV | 1.8 | 11 | Citations (PDF) |
| 158 | Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia | 1.5 | 6 | Citations (PDF) |
| 159 | The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States | 5.6 | 188 | Citations (PDF) |
| 160 | The Role of Behavioral Health in Optimizing Care for Complex Patients in the Primary Care Setting | 3.0 | 20 | Citations (PDF) |
| 161 | Combining Epidemiologic and Biostatistical Tools to Enhance Variable Selection in HIV Cohort Analyses | 2.5 | 11 | Citations (PDF) |
| 162 | Gender-Specific Risk Factors for Virologic Failure in KwaZulu-Natal: Automobile Ownership and Financial Insecurity | 2.0 | 12 | Citations (PDF) |
| 163 | The Continuum of HIV Care in a Veterans' Affairs Clinic | 1.5 | 28 | Citations (PDF) |
| 164 | Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations | 2.1 | 21 | Citations (PDF) |
| 165 | Palliative HIV Care: Opportunities for Biomedical and Behavioral Change | 3.8 | 8 | Citations (PDF) |
| 166 | Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapyAids, 2014, 28, 2531-2539 | 2.4 | 32 | Citations (PDF) |
| 167 | Antiretroviral reduction | 2.4 | 6 | Citations (PDF) |
| 168 | The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa | 0.8 | 30 | Citations (PDF) |
| 169 | Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine | 4.0 | 33 | Citations (PDF) |
| 170 | Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes | 4.0 | 45 | Citations (PDF) |
| 171 | Early Warning Indicators for First-Line Virologic Failure Independent of Adherence Measures in a South African Urban Clinic | 2.8 | 48 | Citations (PDF) |
| 172 | Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States | 1.9 | 123 | Citations (PDF) |
| 173 | A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS) | 2.5 | 16 | Citations (PDF) |
| 174 | High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimenAids, 2012, 26, 1679-1684 | 2.4 | 79 | Citations (PDF) |
| 175 | Second-Line Antiretroviral Therapy | 1.9 | 58 | Citations (PDF) |
| 176 | Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa | 2.5 | 30 | Citations (PDF) |
| 177 | Understanding HIV Risk Behavior from a Sociocultural Perspective | 0.3 | 18 | Citations (PDF) |
| 178 | Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy | 1.9 | 24 | Citations (PDF) |
| 179 | Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS | 2.5 | 50 | Citations (PDF) |
| 180 | Risk Factors Influencing Antibody Responses to Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Antigens in Patients Under Antiretroviral Therapy | 1.9 | 23 | Citations (PDF) |
| 181 | Septic Arthritis Involving Kluyvera Species After Anterior Cruciate Ligament Reconstruction | 0.1 | 0 | Citations (PDF) |
| 182 | Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort | 2.3 | 34 | Citations (PDF) |
| 183 | The Global Status of HIV Drug Resistance: Clinical and Public-Health Approaches for Detection, Treatment and Prevention | 1.0 | 18 | Citations (PDF) |
| 184 | Commentary: Malaria and HIV transmission: old meets new in a deadly partnership or an opportunity for healthcare synergism? | 5.2 | 2 | Citations (PDF) |
| 185 | Clinical Evaluation of the Potential Utility of Computational Modeling as an HIV Treatment Selection Tool by Physicians with Considerable HIV Experience | 2.8 | 21 | Citations (PDF) |
| 186 | HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts | 1.0 | 236 | Citations (PDF) |
| 187 | Are HIV-Positive Persons Progressing Faster After Diagnosis Over the Epidemic? | 1.9 | 7 | Citations (PDF) |
| 188 | Outcomes after virologic failure of first-line ART in South AfricaAids, 2010, 24, 1007-1012 | 2.4 | 60 | Citations (PDF) |
| 189 | Anal cancers among HIV-infected persons: HAART is not slowing rising incidence | 2.4 | 178 | Citations (PDF) |
| 190 | Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study | 2.3 | 75 | Citations (PDF) |
| 191 | CD4 T Cell Count Reconstitution in HIV Controllers after Highly Active Antiretroviral Therapy | 5.6 | 37 | Citations (PDF) |
| 192 | Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature | 0.6 | 83 | Citations (PDF) |
| 193 | Treatment-Mediated Alterations in HIV Fitness Preserve CD4+ T Cell Counts but Have Minimal Effects on Viral Load | 3.3 | 22 | Citations (PDF) |
| 194 | Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals | 2.4 | 40 | Citations (PDF) |
| 195 | The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation | 19.5 | 1,133 | Citations (PDF) |
| 196 | The Effect of Human Immunodeficiency Virus on Hepatitis B Virus Serologic Status in Co-Infected Adults | 2.5 | 27 | Citations (PDF) |
| 197 | Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic | 2.5 | 223 | Citations (PDF) |
| 198 | Development of Dual-class Antiretroviral Drug Resistance in a Child Coinfected with HIV and Tuberculosis: A Case Report from KwaZulu-Natal, South Africa | 1.1 | 1 | Citations (PDF) |
| 199 | Adenovirus Serotype 14 Pneumonia at a Basic Military Training Site in the United States, Spring 2007: A Case Series | 1.0 | 26 | Citations (PDF) |
| 200 | Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study | 4.0 | 284 | Citations (PDF) |
| 201 | In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine | 3.6 | 82 | Citations (PDF) |
| 202 | Responsiveness of T Cells to Interleukin‐7 Is Associated with Higher CD4<sup>+</sup>T Cell Counts in HIV‐1–Positive Individuals with Highly Active Antiretroviral Therapy–Induced Viral Load Suppression | 4.0 | 50 | Citations (PDF) |
| 203 | Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care | 1.9 | 66 | Citations (PDF) |
| 204 | Cutaneous Malignancies Among HIV-Infected Persons | 4.4 | 55 | Citations (PDF) |
| 205 | Is HIV Becoming More Virulent? Initial CD4 Cell Counts among HIV Seroconverters during the Course of the HIV Epidemic: 1985–2007 | 5.6 | 33 | Citations (PDF) |
| 206 | Health Care Transmission of a Newly Emergent Adenovirus Serotype in Health Care Personnel at a Military Hospital in Texas, 2007 | 4.0 | 33 | Citations (PDF) |
| 207 | Outbreak of Severe Respiratory Disease Associated with Emergent Human Adenovirus Serotype 14 at a US Air Force Training Facility in 2007 | 4.0 | 121 | Citations (PDF) |
| 208 | Response: Association of Duffy Antigen Genotypes with HIV-AIDS Susceptibility | 10.6 | 19 | Citations (PDF) |
| 209 | Occupational Exposure to Blood and Other Bodily Fluids at a Military Hospital in Iraq | 2.4 | 8 | Citations (PDF) |
| 210 | Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study | 2.4 | 244 | Citations (PDF) |
| 211 | Hospital-Acquired Device-Associated Infections at a Deployed Military Hospital in Iraq | 2.4 | 11 | Citations (PDF) |
| 212 | Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors' replyAids, 2009, 23, 1791-1792 | 2.4 | 14 | Citations (PDF) |
| 213 | The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients | 1.9 | 21 | Citations (PDF) |
| 214 | The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestryBlood, 2009, 114, 2783-2792 | 1.0 | 60 | Citations (PDF) |
| 215 | CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals | 36.5 | 118 | Citations (PDF) |
| 216 | Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility | 10.6 | 175 | Citations (PDF) |
| 217 | Independent Effects of Genetic Variations in Mannose‐Binding Lectin Influence the Course of HIV Disease: The Advantage of Heterozygosity for Coding Mutations | 4.0 | 32 | Citations (PDF) |
| 218 | Viral Dynamics and In Vivo Fitness of HIV-1 in the Presence and Absence of Enfuvirtide | 1.9 | 20 | Citations (PDF) |
| 219 | Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART | 1.9 | 53 | Citations (PDF) |
| 220 | Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV Seroconverters | 1.9 | 33 | Citations (PDF) |
| 221 | Prevalence of HIV‐1 Drug Resistance after Failure of a First Highly Active Antiretroviral Therapy Regimen in KwaZulu Natal, South Africa | 5.6 | 227 | Citations (PDF) |
| 222 | Apolipoprotein (apo) E4 enhances HIV-1 cell entry
<i>in vitro</i>
, and the
<i>APOE</i>
ε4/ε4 genotype accelerates HIV disease progression | 7.5 | 194 | Citations (PDF) |
| 223 | CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals | 2.5 | 23 | Citations (PDF) |
| 224 | Role of CCL3L1-CCR5 Genotypes in the Epidemic Spread of HIV-1 and Evaluation of Vaccine Efficacy | 2.5 | 23 | Citations (PDF) |
| 225 | HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles | 2.5 | 71 | Citations (PDF) |
| 226 | CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms | 24.9 | 155 | Citations (PDF) |
| 227 | Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations | 1.7 | 60 | Citations (PDF) |
| 228 | Coccidioidal Meningitis after Liver Transplantation in a Nonendemic Region: A Case Report | 0.8 | 8 | Citations (PDF) |
| 229 | Neurocysticercosis | 2.8 | 11 | Citations (PDF) |
| 230 | Primary hyperoxaluria: Report of a patient with livedo reticularis and digital infarcts | 1.1 | 27 | Citations (PDF) |
| 231 | Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members | 1.6 | 22 | Citations (PDF) |
| 232 | OUP accepted manuscript | 5.6 | 0 | Citations (PDF) |
